PTEN counteracts the most critical cancer-promoting PI3 kinase-AKT pathway by dephosphorylating the PI3 kinase product, PI 3,4,5-tris-phosphate (PIP3) to PIP2. This evidence concerns the gene AKT1 and cancer.